STOCK TITAN

Quest Diagnostics to Speak at the Morgan Stanley 19th Annual Global Healthcare Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

Quest Diagnostics (NYSE: DGX) will present at the Morgan Stanley 19th Annual Global Healthcare Conference on September 9, 2021, at 9:30 a.m. ET. CEO Steve Rusckowski and EVP Jim Davis will discuss the company's growth strategy and the COVID-19 pandemic's impact. The presentation will be available for live streaming on the company's investor relations page and will remain archived for later viewing until October 9, 2021.

Positive
  • None.
Negative
  • None.

SECAUCUS, N.J., Aug. 30, 2021 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it is scheduled to speak at the Morgan Stanley 19th Annual Global Healthcare Conference.  Steve Rusckowski, Chairman, CEO and President and Jim Davis, Executive Vice President, General Diagnostics will discuss the company's vision, goals and two-point strategy to accelerate growth and drive operational excellence, as well as the company's current perspective on the impact of the COVID-19 pandemic. The presentation is scheduled for Thursday, September 9, 2021, at 9:30 a.m. Eastern Time.

The presentation will be webcast live during the conference and will be available on the company's investor relations page which can be accessed at ir.QuestDiagnostics.com.  In addition, the archived webcast will be available within 24 hours after the conclusion of the live event and will remain available until October 9, 2021. 

About Quest Diagnostics
Quest Diagnostics empowers people to take action to improve health outcomes. Derived from the world's largest database of clinical lab results, our diagnostic insights reveal new avenues to identify and treat disease, inspire healthy behaviors and improve health care management. Quest Diagnostics annually serves one in three adult Americans and half the physicians and hospitals in the United States, and our nearly 50,000 employees understand that, in the right hands and with the right context, our diagnostic insights can inspire actions that transform lives. www.QuestDiagnostics.com.

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/quest-diagnostics-to-speak-at-the-morgan-stanley-19th-annual-global-healthcare-conference-301365248.html

SOURCE Quest Diagnostics

FAQ

When is Quest Diagnostics scheduled to speak at the Morgan Stanley Global Healthcare Conference?

Quest Diagnostics is scheduled to speak on September 9, 2021, at 9:30 a.m. ET.

Who will represent Quest Diagnostics at the Morgan Stanley conference?

Steve Rusckowski, CEO, and Jim Davis, EVP, will represent Quest Diagnostics.

How can I watch Quest Diagnostics' presentation at the Morgan Stanley conference?

The presentation will be available for live streaming on Quest Diagnostics' investor relations page.

Until when will the archived webcast of Quest Diagnostics' presentation be available?

The archived webcast will be available until October 9, 2021.

What topics will be discussed by Quest Diagnostics at the conference?

They will discuss the company's growth strategy and the impact of the COVID-19 pandemic.

Quest Diagnostics Inc.

NYSE:DGX

DGX Rankings

DGX Latest News

DGX Stock Data

16.99B
111.10M
0.43%
91.55%
2.32%
Diagnostics & Research
Services-medical Laboratories
Link
United States of America
SECAUCUS